Tobacco Free Initiative (TFI)

Development of the meeting

Session one

Session one began with a situational analysis of the tobacco product laboratory capacity with respect to tobacco product regulation, existing laboratories, analyses, methodologies, equipment, facilities, personnel, and needs. Next, a presenter from the US Centers for Disease Control and Prevention (CDC) provided a summary of CDC laboratory activities and the agency’s role in providing scientific data that can inform regulators in the analysis of products, chemistry of tobacco smoke, biomarkers of exposure, and health studies examining the relationship between exposure and tobacco-related diseases.

Session two

Session two focused on the regulatory framework for current and future tobacco products. A paper on a framework for effective tobacco product regulation and a regulated market model for tobacco control was presented.

Session three

Session three examined “light and mild” issues. The session began with a presentation on the use of misleading descriptors on the packaging of tobacco products. Then, there was a brief presentation about the US National Cancer Institute’s Monograph 13, which examines the risk associated with smoking cigarettes and low machine-measured yields of tar and nicotine.

Session four

Session four focused on tobacco industry activities and participation. The session opened with a presentation on the analysis and usage of information provided by tobacco industry representatives in WHO SACTob meetings. Recommendations were discussed regarding the tobacco industry’s presentations in SACTob meetings.

Session five

Session five dealt with regulating constituents of tobacco products, especially nicotine. Opening the session was a presentation on nicotine and its regulation in tobacco and non-tobacco products. Next, the group discussed Australia’s specific experience regarding nicotine policy. Finally, there was a group briefing on menthol and ammonia manipulation in tobacco products, which can alter nicotine dosing.

Concluding remarks

Final recommendations (link to recommendations) were issued in the areas of health claims derived from the ISO/FTC method to measure tar, nicotine, and carbon monoxide yield, and regulation of nicotine in tobacco and non-tobacco products.